Shield will acquire Echodyne, deal worth $5.3 billion, and raise $2.5 billion at a valuation of $28.8 billion.

Shield will acquire Echodyne, deal worth $5.3 billion, and raise $2.5 billion at a valuation of $28.8 billion.